Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance

Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

NCT00414193 ·Status: COMPLETED

Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia

NCT01853982 ·Status: TERMINATED ·Phase: PHASE3

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae

NCT03891433 ·Status: SUSPENDED ·Phase: PHASE4

Study Evaluating BLI-489 and Piperacillin in Healthy Subjects

NCT00894439 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections

NCT02753946 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit

NCT00177814 ·Status: COMPLETED

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

NCT05355350 ·Status: WITHDRAWN ·Phase: PHASE4

Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia

NCT01796717 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

NCT00443885 ·Status: COMPLETED

Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates

NCT00394784 ·Status: WITHDRAWN

Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

NCT07326540 ·Status: RECRUITING ·Phase: PHASE3

A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

NCT03006679 ·Status: WITHDRAWN ·Phase: PHASE3

A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult Participants

NCT03441529 ·Status: COMPLETED ·Phase: PHASE1

Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock

NCT00816790 ·Status: TERMINATED ·Phase: PHASE4

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

NCT03671967 ·Status: RECRUITING ·Phase: PHASE4

An Open-label, Randomized, and Comparative Study to Evaluate the Efficacy and Safety of Cefoperazone/Sulbactam in Comparison to Cefepime for the Treatment of Hospital-acquired Pneumonia and Healthcare-associated Pneumonia

NCT01280461 ·Status: UNKNOWN

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

NCT02493764 ·Status: COMPLETED ·Phase: PHASE3

PK of Piperacillin/Tazobactam in Adults Undergoing ECMO

NCT03467854 ·Status: TERMINATED

A Single-Dose Pharmacokinetics Study of Tapimycin Injection

NCT00924742 ·Status: COMPLETED ·Phase: NA

Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms

NCT00079989 ·Status: COMPLETED ·Phase: PHASE3

Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection

NCT01760109 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)

NCT00336505 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

NCT00195533 ·Status: COMPLETED

Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

NCT01897831 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

NCT03687255 ·Status: COMPLETED ·Phase: PHASE3